2019
DOI: 10.1111/jocs.14129
|View full text |Cite
|
Sign up to set email alerts
|

Successful orthotopic heart transplantation in a patient with Marfan syndrome

Abstract: Cardiovascular diseases represent the leading cause of mortality in patients with Marfan syndrome. Many treatments have been developed for patients with end‐stage heart failure, among which orthotopic heart transplantation remains the gold standard. We report a successful orthotopic heart transplantation for a Marfan syndrome patient in end‐stage heart failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 7 publications
0
2
0
1
Order By: Relevance
“…In contrast, there are several reports on end-stage heart failure necessitating heart transplantation in patients with MFS ( Table 3 ). In addition, heart failure is mentioned as one of the leading causes of death in MFS (see further) [ 15 , 16 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ]. Whether myocardial impairment and development of heart failure in MFS is a primary intrinsic problem or a secondary, stressor-induced problem remains an unanswered question.…”
Section: Pathophysiology Of Marfan Cardiomyopathymentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, there are several reports on end-stage heart failure necessitating heart transplantation in patients with MFS ( Table 3 ). In addition, heart failure is mentioned as one of the leading causes of death in MFS (see further) [ 15 , 16 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ]. Whether myocardial impairment and development of heart failure in MFS is a primary intrinsic problem or a secondary, stressor-induced problem remains an unanswered question.…”
Section: Pathophysiology Of Marfan Cardiomyopathymentioning
confidence: 99%
“…An association between prior aortic or valvular surgery and the development of heart failure as long-term complication in patients with MFS has also been suggested [ 48 , 52 , 53 , 54 ]. In several case reports and one case series describing patients with MFS undergoing orthotopic heart transplantation, almost all patients had a history of prior aortic or valvular surgery ( Table 3 ) [ 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 49 ]. Similarly, a study by Hetzer et al on a cohort of 421 patients with MFS who had undergone cardiac surgery reported cardiomyopathy in 11.2%.…”
Section: Pathophysiology Of Marfan Cardiomyopathymentioning
confidence: 99%
“…De acuerdo a lo anterior el SM se puede presentar con cardiopatía primaria o secundaria (8) . En la insuficiencia cardíaca terminal en pacientes con SM se puede considerar el trasplante cardíaco, ya que es un tratamiento que en muy limitada experiencia ha mostrado eficacia en serie de casos (9) y en reportes (10,11) con sobrevida similar a los pacientes trasplantados sin SM; incluso en algunos pacientes se plantea el trasplante y el reemplazo profiláctico de la aorta ascendente (1) . Sin embargo el trasplante cardíaco debe considerarse en un contexto socioeconómico-cultural adecuado.…”
Section: Discussionunclassified